Chronic Hypoxia Emerging as One of the Driving Forces behind Gene Expression and Prognosis of Hepatocellular Carcinoma
Open Access
- 1 January 2011
- journal article
- Published by Hindawi Limited in ISRN Pathology
- Vol. 2011, 1-10
Abstract
Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors and an important cause of death. It has become evident that the tumor microenvironment, including hypoxia, plays a major role in the development of HCC. This paper focuses on the role of chronic hypoxia in HCC. Recently, we have shown the importance of chronic hypoxia on gene expression and behavior of liver cells. Using a cell culture model, we identified a distinct gene expression pattern and demonstrated clinical relevance for a 7-gene subset that can predict survival and early recurrence in patients. Recently, it was also shown that chronic hypoxia is associated with the upregulation of β-catenin and Hif1α and that suppression of β-catenin reduced the metastatic potential of the tumor. Both studies demonstrate the importance of chronic hypoxia for the prognosis of HCC. Identifying the molecular pathways can help us to understand the mechanisms responsible for tumor aggressiveness.Keywords
This publication has 83 references indexed in Scilit:
- Epithelial-to-Mesenchymal Transition of Murine Liver Tumor Cells Promotes Invasion†,‡Hepatology, 2010
- Chronic systemic hypoxia promotes LNCaP prostate cancer growth in vivoThe Prostate, 2010
- Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to diseaseKidney International, 2009
- Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edgeOncogene, 2009
- The Tumor Microenvironment: The Making of a ParadigmCancer Microenvironment, 2009
- Molecular targeted therapies in hepatocellular carcinoma†Hepatology, 2008
- Cancer-related inflammationNature, 2008
- A Dialogue between the Hypoxia-Inducible Factor and the Tumor MicroenvironmentCancer Microenvironment, 2008
- Hypoxia and cancerJournal of Molecular Medicine, 2007
- Fibroblasts in cancerNature Reviews Cancer, 2006